106.818 articles found

1-ARYLCYCLOALKYL SULPHIDES, SULPHOXIDES AND SULPHONES FOR THE TREATMENT OF DEPRESSION, ANXIETY AND PARKINSON'S DISEASE

HARRIS Paul John, HEAL David John.

· 1994-05-07

Treatment of Parkinson's disease.

Ahlskog JE.

Postgrad Med · 1994-05-01

DOI: 10.1080/00325481.1994.11945830PMID: 29219640

Activation of regional cerebral blood flow by a memorization task in early Parkinson's disease patients and normal subjects.

Démonet JF, Celsis P, Agniel A, Cardebat D, Rascol O, Marc-Vergnes JP.

J Cereb Blood Flow Metab · 1994-05-01

DOI: 10.1038/jcbfm.1994.54PMID: 8163585

Sleep benefit and sleep deprivation in subgroups of depressed patients with Parkinson's disease.

Lauterbach EC.

Am J Psychiatry · 1994-05-01

DOI: 10.1176/ajp.151.5.782bPMID: 8166330

Neurophysiological properties of pallidal neurons in Parkinson's disease.

Sterio D, Berić A, Dogali M, Fazzini E, Alfaro G, Devinsky O.

Ann Neurol · 1994-05-01

DOI: 10.1002/ana.410350512PMID: 8179304

Parkinsonism induced by solvent abuse.

Uitti RJ, Snow BJ, Shinotoh H, Vingerhoets FJ, Hayward M, Hashimoto S, Richmond J, Markey SP, Markey CJ, Calne DB.

Ann Neurol · 1994-05-01

DOI: 10.1002/ana.410350516PMID: 8179306

Risperidone for hallucinations in levodopa-treated Parkinson's disease patients.

Meco G, Alessandria A, Bonifati V, Giustini P.

Lancet · 1994-05-01

DOI: 10.1016/s0140-6736(94)92511-9PMID: 7514254

[Juvenile Parkinson's disease initially presenting as bulbar incoordination: a case report].

Kon K, Sakuragawa N, Kurokawa T.

No To Hattatsu · 1994-05-01

PMID: 8185982

Akinesia in Parkinson's disease. I. Shortening of simple reaction time with focal, single-pulse transcranial magnetic stimulation.

Pascual-Leone A, Valls-Solé J, Brasil-Neto JP, Cohen LG, Hallett M.

Neurology · 1994-05-01

DOI: 10.1212/wnl.44.5.884PMID: 8190292

Akinesia in Parkinson's disease. II. Effects of subthreshold repetitive transcranial motor cortex stimulation.

Pascual-Leone A, Valls-Solé J, Brasil-Neto JP, Cammarota A, Grafman J, Hallett M.

Neurology · 1994-05-01

DOI: 10.1212/wnl.44.5.892PMID: 8190293

Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients.

Nutt JG, Woodward WR, Beckner RM, Stone CK, Berggren K, Carter JH, Gancher ST, Hammerstad JP, Gordin A.

Neurology · 1994-05-01

DOI: 10.1212/wnl.44.5.913PMID: 8190296

Motor response to apomorphine and levodopa in asymmetric Parkinson's disease.

Rodriguez M, Lera G, Vaamonde J, Luquin MR, Obeso JA.

J Neurol Neurosurg Psychiatry · 1994-05-01

DOI: 10.1136/jnnp.57.5.562PMID: 8201324